GZMB and neoplasm: In agreement with these findings, transcriptomic analysis from our lab of tumor/non-tumor samples collected from AA and CA patients found that tumors from AAs present a lower expression of Granzyme B (GZMB) and an impaired infiltration of cytotoxic CD8+ T cells, suggesting an overall decreased antitumoral activity in AAs when compared to CAs (11).